Table 3 Changes in clinical conditions between baseline and year one by defect configuration and treatment. Independent t tests (equal variance not assumed)) failed to demonstrate study group differences in clinical results regardless of defect configuration
From: Impact of bone defect morphology on the outcome of reconstructive treatment of peri-implantitis
Variable | Treatment | 2-wall defects | Treatment | 3-wall defects | Treatment | 4-wall defects | |||
|---|---|---|---|---|---|---|---|---|---|
Mean | SD | Mean | SD | Mean | SD | ||||
Defect fill mean (improvement) (mm)) | AB (n = 16) | 0.4 | 1.5 | AB (n = 14) | 0.1 | 1.9 | AB (n = 5) | 1.7 | 0.8 |
BDX(n = 19) | 1.2 | 1.1 | BDX (n = 10) | 1.4 | 1.8 | BDX (n = 7) | 0.9 | 2.3 | |
PPD mean change (reduction) (mm) | AB (n = 16) | 1.8 | 1.4 | AB (n = 15) | 1.9 | 1.7 | AB (n = 6) | 2.7 | 1.0 |
BDX (n = 19) | 2.5 | 1.6 | BDX (n = 10) | 2.6 | 1.1 | BD (n = 7) | 3.3 | 0.9 | |
BOP % mean change (reduction) | AB (n = 16) | 43.8 | 35.9 | AB (n = 14) | 25.0 | 27.7 | AB (n = 16) | 33.3 | 43.8 |
BDX (n = 19) | 34.2 | 48.0 | BDX (n = 10) | 52.5 | 39.9 | BD (n = 19) | 67.9 | 23.8 | |
Plaque score % mean change (reduction) | AB (n = 15) | 10.0 | 26.4 | ABX (n = 14) | 3.6 | 39.4 | AB (n = 15) | 8.5 | 12.9 |
BDX (n = 20) | 11.3 | 27.4 | BDX (n = 10) | 12.5 | 25.0 | BD (n = 20) | 0.0 | 14.4 | |